share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Li Dean Y

SEC announcement ·  Feb 12 16:08
Summary by Moomoo AI
Li Dean Y, Executive VP & President of Merck & Co's MRL division, completed a sale of 14,702 shares of the company's common stock on February 9, 2024. The shares were sold at an average price of $125.4988, resulting in a total transaction value of approximately $1.85 million. Following the sale, Li's direct holdings in Merck & Co. amounted to 46,242.37 shares. The transaction was executed as an open market or private sale, following an acquisition of the same number of shares through the exercise or conversion of derivative security at a price of $62.07 per share.
Li Dean Y, Executive VP & President of Merck & Co's MRL division, completed a sale of 14,702 shares of the company's common stock on February 9, 2024. The shares were sold at an average price of $125.4988, resulting in a total transaction value of approximately $1.85 million. Following the sale, Li's direct holdings in Merck & Co. amounted to 46,242.37 shares. The transaction was executed as an open market or private sale, following an acquisition of the same number of shares through the exercise or conversion of derivative security at a price of $62.07 per share.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more